Grants for State governments - Federal

The National Institute on Alcohol Abuse and Alcoholism ( NIAAA) intends to reissue RFA-AA-23-001, Specialized Alcohol Research Centers (P50, Clinical Trial Optional), by publishing a NOFO to solicit applications for a broad-based Alcohol Research Centers program to foster and conduct interdisciplinary, collaborative research on Alcohol Use Disorder (AUD), alcohol misuse and alcohol-related problems, and other health-related consequences across the lifespan. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The NOFO is expected to be published in Spring 2024 with an expected application due date in Fall 2024. This NOFO will utilize the P50 activity code. Details of the planned NOFO are provided below.

The U.S. Geological Survey (USGS) Landslide Hazards Program (LHP) issues this Program Announcement for assistance to support communication, planning, coordination, mapping, assessments, and data collection of landslide hazards. The program announcement for the Cooperative Landslide Hazard Mapping and Assessment Program is authorized by the National Landslide Preparedness Act (P.L. 116-323) and appropriations to the USGS.A main objective of this Program, as outlined in the National Landslide Preparedness Act, is to provide grants, on a competitive basis, to state, territorial, local, and Tribal governments to research, map, assess, and collect data on landslide hazards within the jurisdictions of those governments. This funding opportunity, USGS Cooperative Landslide Hazard Mapping and Assessment Program, solicits Risk Reduction Proposals as described in this document.

The NIH Directors Pioneer Award Program supports individual scientists of exceptional creativity who propose bold and highly innovative research projects with the potential to produce a major impact on broad, important areas relevant to the mission of NIH. To support innovative and novel research across the vast NIH mission, individuals from diverse backgrounds (including those from underrepresented groups; see Notice of NIHs Interest in Diversity) and from the full spectrum of eligible institutions in all geographic locations are encouraged to apply to this Notice of Funding Opportunity. Applications in all topics relevant to the broad mission of NIH are welcome, including, but not limited to, topics in the behavioral, social, biomedical, applied, and formal sciences and topics that may involve basic, translational, or clinical research. The NIH Directors Pioneer Award is a component of the High-Risk, High-Reward Research (HRHR) Program of the NIH Common Fund.

This grant provides funding to higher education institutions and nonprofit organizations to train future professionals in vocational rehabilitation services for individuals with disabilities, addressing personnel shortages in the field.

This funding opportunity provides financial support to organizations implementing strategies to prevent diabetes and improve health equity for populations at risk, focusing on statewide, local, or multisectoral approaches.

This funding opportunity supports research centers focused on understanding how biological sex differences affect women's health, promoting interdisciplinary collaboration and workforce diversity in the scientific community.

This funding opportunity supports the establishment of a center that fosters collaboration between researchers in substance use epidemiology and prevention to develop effective strategies for preventing substance use and related issues.

This funding opportunity provides financial support to state and tribal governments to improve prescription drug monitoring systems, enhance data sharing, and combat the misuse of controlled substances, particularly opioids.

This grant provides funding to support arts education initiatives for disadvantaged students and those with disabilities, focusing on professional development for educators and partnerships with cultural organizations.

Synopsis: NOFO # DD24-0051 solicits non-research, cooperative agreement applications to conduct population-based surveillance of congenital heart defects (CHD) to describe health outcomes including health equity, with the goal of identifying opportunities to improve the health of all people living with CHD. This project will involve a required component (A) and an optional component (B). The population included in this surveillance activity can be an entire state or a region within a state. Individuals with CHD should be identified through existing data sources including the jurisdiction birth defects surveillance system, electronic health records, administrative data (e.g., Medicaid/Medicare, hospital discharge), or other sources available to funding recipients. Background: Congenital heart defects (CHD) affect about 1% of all births in the United States, and are a leading cause of birth defect-associated infant mortality, morbidity, and healthcare costs. Improvements in early detection and treatment of CHD and consequently in survival have resulted in many people, including those affected by a severe CHD, living into adolescence and adulthood. An estimated two million persons in the U.S. are living with a CHD, including over one million adults; about 12% of these affected adults have a severe CHD. Most current efforts to conduct population-based surveillance of CHD have focused on monitoring newborns. However, little data exist on the descriptive epidemiology of CHD beyond early childhood in the U.S. Despite the public health burden, the lack of population-based surveillance precludes reliable data on people with CHD, their survival, healthcare utilization, and characteristics associated with long-term outcomes. Through this surveillance activity, these data will be assessed, enabling and informing efforts to improve the health and well-being of people with CHD. Objectives: Component A objectives include: (1) assess survival, comorbidities, healthcare utilization during the period 2021-2023, and characteristics associated with long-term outcomes among people with CHD; (2) assess health equity among people with CHD; (3) examine state and national healthcare policies that have an impact on people with CHD; (4) examine COVID-19 and related data such as health care utilization during the pandemic among people with CHD; and (5) work with local/state partners to use site-specific CHD data. Component B objectives include: (1) develop and refine a machine learning algorithm for the surveillance data collected through Component A; and (2) apply this machine learning algorithm to data collected from all recipients funded through Component A.

This grant provides funding for U.S.-based researchers, including advanced graduate students, to participate in Earth-based simulations that support the planning and execution of future lunar missions under the Artemis program.

This funding opportunity supports experienced researchers looking to expand their expertise or shift their career focus through advanced training and research experiences at various institutions.

Fiscal Year 2024 Key Objectives Application proposals must include at least one of the following three objectives identified below. Proposals may contain more than one objective. As noted in Section 4, applicants must map their proposed activities and indicators measuring success to the objective(s) using the Activities/Indicators Tracker. If awarded, grantees will be required to use the FNS-908 Performance Progress Report to report on progress towards activities that align with the required objective(s) listed on the Activities/Indicators Tracker. Carefully considering proposed activities and indicators will prepare grantees for their performance progress reporting requirements if awarded. The project examples aligned with each objective listed below are only suggestions. A PTIG project may assist State agencies in making investments in systems to improve efficiency, provide excellent customer service, and meet Federal standards as they face unprecedented operational challenges. FNS welcomes other projects that support these objectives and encourages applicants to propose innovative ideas to solve both common and unique problems associated with SNAP application and eligibility processes. 1. Modernize SNAP customer service and client communication to improve accessibility, transparency, and responsiveness in processing applications and determining eligibility. 2. Improve administrative infrastructure and day-to-day SNAP operations in processing applications and determining eligibility. 3. Invest in technology and systems to encourage cross collaboration and cross enrollment between SNAP and other Federal, State, and local assistance programs. Please read the full announcement for additional details.

PD Eswatini invites proposals for programs that strengthen cultural ties between the U.S. and Eswatini through cultural and exchange programming that highlights shared values and promotes bilateral cooperation. All programs must include an American cultural element, or connection with American expert/s, organization/s, or institution/s in a specific field that will promote increased understanding of U.S. policy and perspectives. Examples of PD Small Grants Program programs include, but are not limited to: Academic and professional lectures, seminars and speaker programs; Artistic and cultural workshops, joint performances and exhibitions; Cultural heritage conservation and preservation programs; Professional and academic exchanges and programs; Programs developed by an alumnus of a U.S.-sponsored or supported educational or professional exchange program.

This funding opportunity supports innovative research into the biological mechanisms behind complex brain disorders, targeting a wide range of eligible applicants including universities, nonprofits, and small businesses.

The Integrated Atmospheric Deposition Network (IADN) was established in 1990 as a binational monitoring network between the U.S. Environmental Protection Agency (EPA) and Environment and Climate Change Canada (ECCC), in response to scientific evidence that demonstrated that input from the atmosphere is a significant source of many persistent toxic chemicals to the Great Lakes. Since 1990, IADN has monitored persistent toxic chemicals in vapor, particulates, and precipitation at both urban and rural sites across the Great Lakes basin. Master stations are in rural areas on four of the Great Lakes (Eagle Harbor, MI; Sleeping Bear Dunes, MI; Sturgeon Point, NY; ECCC Station: Point Petre, ON) to characterize the background basin-wide trends of persistent toxic chemical loadings to the lakes. Satellite stations are also located in two urban areas (Chicago, IL and Cleveland, OH) to better understand the contribution of large urban areas to persistent toxic chemical loadings to the Great Lakes. All stations are operated by EPA, except for Point Petre which is operated by ECCC. Funding for IADN is provided by the Great Lakes Restoration Initiative (GLRI or Initiative). The GLRI builds on the prior efforts of federal, state, and local agencies; Indian Tribes; businesses; public interest groups; interested citizens; and others to develop a collaborative and comprehensive approach to restoring the Great Lakes. Information about the Initiative can be found at GLRI.us. The statutory authority of the GLRI to award cooperative agreements is contained in the Clean Water Act, Section 118(c)(7), as amended by Public Law 114-322. The EPA has authority to award grants and cooperative agreements for planning, research, monitoring, outreach, and implementation projects in furtherance of the GLRI and the Great Lakes Water Quality Agreement (GLWQA).This Request for Applications (RFA) solicits applications from eligible entities for a cooperative agreement to be awarded pursuant to the statutory authority referenced above and the GLRI Action Plan III.

This grant provides funding to U.S. agricultural entities to develop and expand markets for American agricultural exports in emerging markets, fostering collaboration and knowledge exchange.

This funding opportunity supports a wide range of organizations in developing innovative drug therapies for Alzheimer's disease and related dementias, focusing on non-traditional treatment targets and requiring collaboration with NIH throughout the clinical trial process.

This funding opportunity supports innovative research into new risk factors for liver cancer, particularly focusing on non-viral causes and their interactions with established risks, aimed at improving prevention strategies in the U.S. population.

This funding opportunity provides financial support for researchers and organizations to investigate the factors driving tuberculosis transmission and develop innovative methods for prevention and detection in high-burden areas.